Advertisement

Topics

Building confidence in biosimilars

06:23 EST 15 Feb 2018 | Generics and Biosimilars Initiative

The third Multi-stakeholder Workshop on Biosimilar Medicinal Products included a session on ‘Building Stakeholder Confidence in Biosimilar Medicines through Evidence-Based Information Sharing’ [1]. The session focused on clinical experience of switching and clarifying definitions of ‘interchangeability’ between the US and the European Union (EU).

Original Article: Building confidence in biosimilars

NEXT ARTICLE

More From BioPortfolio on "Building confidence in biosimilars"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Biosimilars
Biosimilars or Follow-on biologics are terms used to describe officially approved subsequent versions of innovator biopharmaceutical products made by a different sponsor following patent and exclusivity expiry on the innovator product. Products that ar...